Analytical Data
-
基因名
ugl
- Application
-
别名
Glycosaminoglycan hydrolase Glycuronidase Unsaturated uronic acid hydrolase
-
种属
Bacillus sp.
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9RC92
-
表达区间
1-377aa
-
分子量
58.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ugl (Ubiquitin-like protein) is increasingly recognized for its significant roles in cellular processes such as protein degradation, signaling, and cellular stress responses. Research into Ugl and its recombinant proteins focuses on understanding its structure-function relationships and exploring its potential therapeutic applications. The ability to produce Ugl recombinantly allows for detailed studies of its various isoforms, interactions with other proteins, and the implications of its post-translational modifications. This has implications in fields ranging from cancer biology, where dysregulation of ubiquitination pathways can lead to tumorigenesis, to neurodegenerative diseases, where proper protein homeostasis is crucial. Moreover, Ugl's role in modulating immune responses and its potential as a drug target for various diseases further underline the importance of this research. As scientists develop novel recombinant technologies, the characterization and functionality of Ugl proteins will provide insights needed for innovative therapeutic strategies and biomarker development, ultimately enhancing our understanding of fundamental biological mechanisms and their applications in medicine.
